ReviewJournal of the American Society of Nephrology : JASN2017
The ESRD Quality Incentive Program-Can We Bridge the Chasm?
Review in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 65 citations in OpenAlex.
- Process evaluation of the RaDIANT community study: a dialysis facility-level intervention to increase referral for kidney transplantation.BMC nephrology · 2018Trial
- Hospital readmissions among adults with chronic kidney disease by HIV status in the United States.AIDS (London, England) · 2026Article
- Quality Metrics in Dialysis: It Takes a Village.Advances in kidney disease and health · 2025Review
- Lessons from implementation of a nephrology key performance indicator programme.Internal medicine journal · 2025Article
- Optimizing Quality Care within a Bundled Framework.Journal of the American Society of Nephrology : JASN · 2025Article
- Physician Payment Incentives and Active Surveillance in Low-Risk Prostate Cancer.JAMA network open · 2025Article
- Pay-for-performance programs effectiveness in healthcare: the case of the end-stage renal disease quality incentive program.The European journal of health economics : HEPAC : health economics in prevention and care · 2024Article
- Hemodialysis facility star rating affects mortality in chronic hemodialysis patients: a longitudinal observational cohort study.Kidney research and clinical practice · 2023Article
- Global Policy Barriers and Enablers to Exercise and Physical Activity in Kidney Care.Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2022Article
- The Role of Dialysis Organizations in Promoting and Facilitating Access to Nondialytic Treatment Options.Kidney medicine · 2022Article
- Value-Based Care and Kidney Disease: Emergence and Future Opportunities.Advances in chronic kidney disease · 2022Review
- Trends in Dialysis Industry Consolidation After Medicare Payment Reform, 2006-2016.JAMA health forum · 2021Article
- Trends in Mineral Metabolism Treatment Strategies in Patients Receiving Hemodialysis in the United States.Clinical journal of the American Society of Nephrology : CJASN · 2020Article
- Engaging patients and family members to design and implement patient-centered kidney disease research.Research involvement and engagement · 2020Article
- Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery.Journal of the American Society of Nephrology : JASN · 2020Review
- An Environmental Scan and Evaluation of Home Dialysis Quality Indicators Currently Used in Canada.Canadian journal of kidney health and disease · 2020Article
- An Environmental Scan of Canadian Quality Metrics for Patients on In-Center Hemodialysis.Canadian journal of kidney health and disease · 2020Article
- Exploring Care Attributes of Nephrologists Ranking Favorably on Measures of Value.Journal of the American Society of Nephrology : JASN · 2019Article
- Value-Based Kidney Care: Aligning Metrics and Incentives to Improve the Health of People with Kidney Disease.Journal of the American Society of Nephrology : JASN · 2019Article
- Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System.JAMA internal medicine · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ESRD Quality Incentive Program (QIP) is the first mandatory federal pay for performance program launched on January 1, 2012. The QIP is tied to the ESRD prospective payment system and mandated by the Medicare Improvements for Patients and Providers Act of 2008, which directed the Centers for Medicare and Medicaid Services to expand the payment bundle for renal dialysis services and legislated that payment be tied to quality measures. The QIP links 2% of the payment that a dialysis facility receives for Medicare patients on dialysis to the facility's performance on quality of care measures. Quality measures are evaluated annually for inclusion on the basis of importance, validity, and performance gap. Other quality assessment programs overlap with the QIP; all have substantial effects on provision of care as clinicians, patients, regulators, and dialysis organizations scramble to keep up with the frequent release of wide-ranging regulations. In this review, we provide an overview of quality assessment and quality measures, focusing on the ESRD QIP, its effect on care, and its potential future directions. We conclude that a patient-centered, individualized, and parsimonious approach to quality assessment needs to be maintained to allow the nephrology community to further bridge the quality chasm in dialysis care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.